Pharmaceutical / Drug Definition :
Lactulose=Produces osmotic effect, which increases water content in colon and enhances peristalsis. Breakdown products in colon lead to acidification of colonic contents, softening of feces, and decreased ammonia absorption from colon to systemic circulation. These effects reduce blood ammonia level in portal-system encephalopathy.
In the United States, Lacosamide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Lacosamide.
Registrar Corp assists Lacosamide companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Lacosamide (Lacosamide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Lacosamide (Lacosamide Suppliers)
- Processors Lacosamide
- Repackers Lacosamide
- Relabelers Lacosamide
- Exporters Lacosamide
- Importers Lacosamide
For more information about Lacosamide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.